Actos Lawsuits Filed for Bladder Cancer and Heart Attacks
Actos, the brand name for the type 2 diabetes drug pioglitazone, has been the subject of health warnings throughout the world due to findings that it may increase a patient’s risk of bladder cancer. On June 15, 2011, the FDA released an Actos Bladder Cancer Warning. The agency announced that recent research indicated that Actos and any other drug containing pioglitazone put patients at higher risk of bladder cancer if they had taken Actos for a year or more. In order to make this information available to patients, a warning about Actos bladder cancer risks was also added to the pamphlet that comes as an insert with the drug. Despite the evidence that Actos bladder cancer is most common in patients who have taken the drug for a year or more, the FDA has not banned the drug and, furthermore, recommends that patients already taking Actos continue to do so. Actos was ranked in the top ten of most popular prescription drugs taken in the United States during 2008. Takeda Pharmaceuticals, the manufacturer of the drug, is bound to face thousands of Actos bladder cancer lawsuits as a result of the newest findings.
Other countries’ safety boards have responded more severely to the Actos bladder cancer danger. The medical safety agencies of both France and Germany issued Actos bladder cancer warnings during June of 2011 which banned the drug for use in those countries until further conclusions about Actos bladder cancer risks could be drawn. Actos is contraindicated for people with bladder cancer, or who have a history of bladder cancer. In addition to increasing a patient’s risk for bladder cancer Actos has been found to increase the likelihood of arm and hand fracture in female patients, as well as lead to congestive heart failure.
Many people wonder when Actos bladder cancer links were discovered, what the FDA Actos Bladder Cancer Warning said, who they should contact for an Actos bladder cancer attorney, or how they should seek legal help. The information here is designed to answer the questions you may have if you or a family member who has taken Actos has been diagnosed with bladder cancer.